Clinical Cancer Genomics Team

Joanne M. Jeter, M.D. is a Professor, Division of Medical Oncology, Department of Medical Oncology & Therapeutics Research, Duarte, California.

Recruited to the Department of Medical Oncology in November 2021 from The Ohio State University Comprehensive Cancer Center, Heather is an internationally-recognized cancer genetic counselor and researcher with a particular emphasis on universal tumor screening of all colorectal and endometrial cancer patients for Lynch syndrome.

Full bio

Kathleen leads City of Hope's Intensive Course in Cancer Genetic Risk Assessment. She is a senior genetic counselor in the Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research at City of Hope.

Full bio

City of Hope, Duarte, CA

Dr. Gray is associate professor and chief of the Division of Clinical Cancer Genomics within the Department of Medical Oncology & Therapeutics Research and a secondary appointment in the Department of Population Sciences.

Full bio

An internationally recognized cancer geneticist and oncologist, Dr. Gruber is a physician-scientist who focuses his clinical practice and research program on precision medicine and the genomics of cancer in order to improve treatment and care for cancer patients and their families.

Full bio

Dr. Idos is a board-certified gastroenterologist and trained cancer geneticist, who specializes in the care of patients with Lynch syndrome, FAP (familial adenomatous polyposis) and other inherited syndromes. The goal of his research is to find new ways to prevent cancer and to improve treatment and care for cancer patients.

Full bio

Dr. McDonnell specializes in medical oncology and clinical cancer genetics. Named a Top Cancer Doctor by Los Angeles Magazine, Dr. McDonnell brings more than two decades of expertise to his current role at City of Hope.

Full bio

Dr. Park brings a passion for genetics research and a veteran caregiver’s empathy to her position as clinical geneticist at City of Hope.

Full bio

Bita Nehoray, M.S., CGC, is a licensed, board-certified genetic counselor specializing in cancer genetics. She received her master's in human genetics and genetic counseling from Stanford University. Bita joined City of Hope's Division of Clinical Cancer Genomics in 2012, where she provides cancer genetics services for patients and families suspected of having a hereditary predisposition to cancer, focusing on Li-Fraumeni syndrome and clonal hematopoiesis of indeterminate potential.

Full bio

Ilana is a manager of the Precision Medicine Program and a licensed, board-certified genetic counselor specializing in cancer genetics. She received her master’s degree in genetic counseling from the Johns Hopkins/National Human Genome Research Institute. Ilana joined the City of Hope Division of Clinical Cancer Genomics in 2013, where she has provided cancer genetics services for patients and families suspected to have a hereditary predisposition to cancer. Since 2019 she has also managed and developed City of Hope’s Precision Medicine Program to provide all City of Hope patients with genomic-driven care.

She has research interests in health care communication and implementation, genetic literacy, and ELSI in genomics. She helped co-develop Helping Oncology Patients Explore (HOPE) Genomics: A patient-directed IT platform for cancer genome sequencing education and return of results. She is faculty for the City of Hope Intensive Course in Genetic Cancer Risk Assessment. She is an active member of the National Society of Genetic Counselors and Southern California Genetic Counselors.

Sandra is a manager in the Division of Clinical Cancer Genomics in City of Hope.

Full bio

Lauren is a genetic counselor in the Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research at City of Hope.

Full bio

Christina is a genetic counselor at The City of Hope Orange County Lennar Foundation Cancer Center. 

Education 

• 2006, Master of Science, Genetic Counseling, University of South Carolina, Columbia, SC 
• 2001, Bachelor of Arts, English, Duke University, Durham, NC 

Professional Experience 

• 2022-present, Genetic Counselor, City of Hope National Medical Center, Duarte, CA 
• 2021-2022, Telehealth Genetic Counselor, Natera, Austin, TX 
• 2018-2021, Senior Genetic Counselor, Integrated Genetics, Santa Fe, NM 
• 2018, Senior Genetic Counselor, Human Longevity, San Diego, CA 
• 2017-2018, Genetic Counselor, Human Longevity, San Diego, CA 
• 2014-2017, Cancer Genetic Counselor, City of Hope National Medical Center, Duarte, CA 
• 2008-2014, Genetic Counselor, Fox Chase Cancer Center, Philadelphia, PA 
• 2006-2008, Coordinator, Family Risk Evaluation Program and Genetic Counselor, St. Mary Medical Center, San Francisco, CA 

Memberships 

• 2006-present, National Society of Genetic Counselors 
• 2006-present, Cancer SIG 
• 2017-present, Precision Medicine SIG (2019-2021, Co-Chair, Elective Genome Sequencing Subcommittee) 
• 2019-present, Prenatal SIG 
• 2019-present, ART and Infertility SIG 

Publications 

• Kilbride, M.K., Egleston, B.L., Hall, M.J., Patrick-Miller, L.J., Daly, M.B., Ganschow, P., Grana, G., Olopade, O.I., Fetzer, D., Brandt, A., Chambers, R., Clark, D.F., Forman, A., Gaber, R., Gulden, C., Horte, J., Long, J.M., Lucas, T., Madaan, S., Mattie, K., McKenna, D., Montgomery, S., Nielsen, S., Nielsen, S., Powers, J., Rainey, K., Rybak, C., Savage, M., Seelaus, C., Stoll, J., Stopfer, J.E., Yao, X.S., Domchek, S.M., & Bradbury, A.R. (2020). Longitudinal follow-up after telephone disclosure in the randomized COGENT study. Genet Med. 22(8)1401-1406. 
• Hou, Y.C., Yu, H.C., Martin, R., Cirulli, E.T., Schenker-Ahmed, N.M., Hicks, M., Cohen, I.V., Jonsson, T.J., Heister, R., Napier, L., Swisher, C.L., Dominguez, S., Tang, H., Li, W., Perkins, B.A., Barea, J., Rybak, C., Smith, E., Duchicela, K., Doney, M., Brar, P., Hernandez, N., Kirkness, E.F., Khan, A.M., Venter, J.C., Karow, D.S., & Caskey, C.T. (2020) Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging. Proc Natl Acad Sci USA. 117(6):3053-3062. 
• Solomon, I., Rybak, C., Van Tongeren, L., Kuzmich, L., Blazer, K., Nehoray, B., Niell-Swiller, M., Bray, S., Bray, T.H., Hurley, K., Weitzel, J.N., & Slavin, T.P. (2019) Experience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family Conference. J Cancer Educ. 34(6):1204-1212. 
• Beri, N., Patrick-Miller, L.J., Egleston, B.L., Mall, M.J., Domchek, S.M., Daly, M.B., Ganschow, P., Grana, G., Olopade, O.I., Fetzer, D., Brandt, A., Chambers, R., Clark, D.F., Forman, A., Gaber, R., Gulden, C., Horte, J., Long, J., Lucas, T., Madaan, S., Mattie, K., McKenna, D., Montgomery, S., Nielsen, S., Powers, J., Rainey, K., Rybak, C., Savage, M., Seelaus, C., Stoll, J., Stopfer, J.E., Yao, X.S., & Bradbury, A.R. (2019) Preferences for in-person person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication of Genetic Test Results by Telephone study. Clin Genet. 95(2):293-301. 
• Hall, M.J., Patrick-Miller, L.J., Egleston, B.L., Domchek, S.M., Daly, M.D., Ganschow, P., Grana, G., Olopade, O.I., Fetzer, D., Brandt, A., Chambers, R., Clark, D.F., Forman, A., Gaber, Gulden, C., Horte, J., Long, J.M., Lucas, T., Madaan, S., Mattie, K., McKenna, D., Montgomery, S., Nielsen, S., Powers, J., Rainey, K., Rybak, C., Savage, M., Seelaus, C., Stoll, J., Stopfer, J.E., Yao, X.S., & Bradbury, A.R. (2018) Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone Study. JCO Precis. Oncol. doi:10.1200/PO.18.00199. Epub 2018 Dec. 18 
• Slavin, T.P., Van Tongeren, L.R., Behrendt, C.E., Solomon, I., Rybak, C., Nehoray, B., Kuzmich, L., Niell-Swiller, M., Blazer, K.R., Tao, S., Yang, K., Culver, J.O., Sand, S., Castillo, D., Herzog, J., Gray, S.W., & Weitzel, J.N. (2018) Prospective Study of Cancer Genetic variants: Variation in Rate of Reclassification by Ancestry by Ancestry. J Natl Cancer Inst. 110(10):1059-1066. 
• Bradbury, A.R., Patrick-Miller, L.J., Egleston, B.L., Hall, M.J., Domchek, S.M., Daly, M.B., Ganschow, P., Grana, G., Olopade, O.I., Fetzer, D., Brandt, A., Chamber, R., Clark, D.F., Forman, A., Gaber, R., Gulden, C., Horte, J., Long, J.M., Lucas, T., Madaan, S., Mattie, K., McKenna, D., Montgomery, S., Nielsen, S., Powers, J., Rainey, K., Rybak, C., Savage, M., Seelaus, C., Stoll, J., Stopfer, J.E., & Yao, X.S. (2018) Randomized Non Inferiority Trial of Telephone vs. In-Person Disclosure of Germline Cancer Genetic Test Results. JNCI 110 (9):985-993. 
• Weitzel, J.N., Chao, E.C., Nehoray, B., Van Tongeren, L.R., LaDuca, H., Blazer, K.R., S. Lavin, T., Pesaran, T., Rybak, C., Solomon, I. Niell-Swiller, M., Dolinsky, J.S., Castillo, D., Elliott, A., Gau, C.L., Speare, V., & Jasperson, K. (2018) Somatic TP53 variants frequently confound germ-line testing results. Genet Med. 20(8):809-816. 
• Slavin, T.P., Neuhausen, S.L., Nehoray, B., Niell-Swiller, M., Solomon, I., Rybak, C., Blazer, K., Adamson, A., Yang, K., Sand, S., Guerrero-Llamas, N., Castillo, D., Herzog, J., Wu, X., Tao, S., Raja, S., Chung, V., Singh, G., Nadesan, S., Brown, S., Cruz-Correa, M., Peterson, G.M., & Weitzel, J. Clinical Cancer Genomics Community Research Network (CCGCRN).(2018) The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconic anemia genes. Fam Cancer. 17(2):235-245. 

Susan is a licensed, board-certified senior genetic counselor specializing in cancer genetics. She has a Master of Science degree in genetic counseling from University of California Irvine. Before completing her master’s degree, Shehayeb earned her bachelor’s degree in molecular, cell and developmental biology from University of California, Los Angeles.

Full bio

Alex is a licensed board-certified genetic counselor specializing in cancer genetics at City of Hope. She received her Master of Science in Human Genetics and Genetic Counseling from Keck Graduate Institute. Before completing her master’s degree, she earned her bachelor’s degree from the University of Connecticut. She is a member of the National Society of Genetic Counselors and the Southern California Genetic Counselors. Her background in the nonprofit sector, with a focus on STEM education for underserved youth, and advocacy for healthcare equality shape her research interests. These include increasing accessibility to cancer genetics services through alternative service delivery models and expanding genomics education for patients and providers. Her graduate school research investigated providers' opinions on the importance of informed consent, barriers to pre-test counseling, and the utility of educational tools in cancer genetics. 

Education 

• 2021, Master of Science in Human Genetics and Genetic Counseling, Keck Graduate Institute, Claremont, CA 
• 2016, Bachelor of Science in Business Management, University of Connecticut, Storrs, CT 

Memberships 

• National Society of Genetic Counselors 
• Southern California Genetic Counselors 

Professional Experience 

• 2021-present, Associate Genetic Counselor, City of Hope, Duarte, CA

Anuja is a genetic counselor in the Division of Clinical Cancer Genomics at City of Hope. 

Education 

• 2019, Master of Science, genetic counseling, Brandeis University, Waltham, MA 
• 2014, Bachelor of Science (Honors), life sciences (specialization in biomedical science), National University of Singapore, Singapore 

Professional Experience 

• 2023-present, Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA 
• 2022-2023, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA 
• 2019-2022, Cancer Genetic Counselor, Division of Clinical Genetics, Miami Cancer Institute, Baptist Health Miami Cancer Institute, Kendall, FL 
• 2018-2019, Coordinator of Office Management, Prevention, Advocacy & Resource Center, Brandeis University Prevention Team, Brandeis University, Waltham, MA 
• 2014-2017, Research Officer, National Heart Centre Singapore, National Heart Research Institute Singapore, Singapore 

Publications 

• Mehta, A., Ramachandra, C.J., Singh, P., Chitre, A., Lua, C.H., Mura, M., Crotti, L., Wong, P., Schwartz, P.J., Gnecchi, M., & Shim, W., 2018. Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model. European Heart Journal, 39(16), pp.1446-1455. 
• Mehta, A., Ramachandra, C.J., Chitre, A., Singh, P., Lua, C.H., & Shim, W. 2017. Acetylated signal transducer and activator of transcription 3 functions as molecular adaptor independent of transcriptional activity during human cardiogenesis. Stem cells, 35(10), pp.2129-2137. 
• Ramachandra, C.J., Mehta, A., Lua, C.H., Chitre, A., Ja, K.M.M., & Shim, W. 2016. ErbB receptor tyrosine kinase: A molecular switch between cardiac and neuroectoderm specification in human pluripotent stem cells. Stem cells, 34(10), pp.2461-2470. 
• Shen, Y.J., Le Bert, N., Chitre, A.A., Koo, C.X.E., Nga, X.H., Ho, S.S., Khatoo, M., Tan, N.Y., Ishii, K.J., & Gasser, S. 2015. Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cells. Cell Reports, 11(3), pp.460-473. 

Kathryn is a genetic counselor in the Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, at City of Hope. 

Education 

• 2020, Master of Science, Human Genetics and Genetic Counseling, Stanford University
• 2017, Bachelor of Science, Biological Sciences, University of California, Irvine 

Professional Experience 

• 2022-present, Genetic Counselor, City of Hope National Medical Center, Duarte, CA
• 2020-2022, Cancer Genetic Counselor, Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA
• 2017-2018, Genetic Counselor Assistant, Patty and George Hoag Cancer Center, Newport Beach, CA 

Publications 

• Solomon, I. B., Boyd, P., Xiao, Y., Reyes, K., Mochizuki, A., Currey, M., Garcia, M., Luong, M., Cheung, F., Gruber, S. B., Hampel, H., Labib, S., Mak, A., Qiao, R., Tang, S., Davey, S., & Gray, S. W. (2026). A Scalable New Model of Germline Cancer Genomic Care Delivery: Assessing Psychological Outcomes. Genetics in medicine : official journal of the American College of Medical Genetics, 102537. Advance online publication. https://doi.org/10.1016/j.gim.2026.102537
• Reyes, K.G., Clark, C., Gerhart, M., Newson, A.J., & Ormond, K.E. “‘I wish that there was more info’: Characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants.” Familial Cancer (2021). https://doi.org/10.1007/s10689-021-00251-3
• Clark, C.R., Reyes, K., Ormond, K.E., Caleshu, C., & Moscarello, T. “U.S. Genetic counselors’ perceptions of inpatient genetic counseling: A valuable model for medically complex patients.” Journal of Genetic Counseling (2021). https://doi.org/10.1002/jgc4.1435
• Reyes, K.G. “Physical Activity and Body Composition in Toddlers with Neurodevelopmental Disorders.” Francisco J. Ayala School of Biological Sciences Journal of Undergraduate Research (2015). 

Hunaydah is an associate genetic counselor in the Division of Clinical Cancer Genomics at City of Hope. 

Education 

• 2021, Master of Science, Genetic Counseling, University of Cincinnati, Cincinnati Children’s Hospital, Cincinnati, OH 
• 2018, Bachelor of Science (Honors), Biomedical Science with CO-OP magna cum laude, University of Ottawa, Ottawa, Canada 

Professional Experience 

• 2021-present, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA 

Publications 

• Elfarawi, H., Tolusso, L., McGowan, M.L., Cortezzo, D., & Vawter-Lee, M. Alobar holoprosencephaly: Exploring mothers' perspectives on prenatal decision-making and prognostication. Prenat Diagn. 2022 May;42(5):617-627. 
• Elfarawi, H., Tolusso, L., McGowan, M., Cortezzo, D.M., & Vawter-Lee, M. Alobar holoprosencephaly: Parental perspectives on prenatal decision-making, prenatal provider prognostication, and quality of life [Abstract 116]. International Society of Prenatal Diagnosis, 2021. 
• Marshall, S., Bayley, M., McCullagh, S., Berrigan, L., Fischer, L., Ouchterlony, D., Rockwell, C., Velikonja, D., et al. Guideline for Concussion/Mild Traumatic Brain Injury and Prolonged Symptoms: 3rd Edition (for Adults 18+ years of age). Ontario Neurotrauma Foundation, 2018. 

Ashley is a genetic counselor in the Division of Clinical Cancer Genomics at City of Hope. 

Education 

• Master of Science, Genetic Counseling, 2022, Northwestern University, Chicago, IL
• Bachelor of Science, Molecular, Cell and Developmental Biology, Dean’s Honors List, 2018, University of California Los Angeles, Los Angeles, CA 

Professional Experience 

• 2025-present, Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
• 2022-2025, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA

Publications 

• Fujii, C.(Co-first author), Mochizuki, A.(Co-first author), Dreike, S., & Jeter, J. M. (2025). Genetic Drivers in Sebaceous Neoplasms: A Review of Germline and Somatic Mutations and Their Role in Treatment and Management Strategies. Cancers, 17(4), 659. https://doi.org/10.3390/cancers17040659
• Solomon, I. B., Boyd, P., Xiao, Y., Reyes, K., Mochizuki, A., Currey, M., Garcia, M., Luong, M., Cheung, F., Gruber, S. B., Hampel, H., Labib, S., Mak, A., Qiao, R., Tang, S., Davey, S., & Gray, S. W. (2026). A Scalable New Model of Germline Cancer Genomic Care Delivery: Assessing Psychological Outcomes. Genetics in medicine : official journal of the American College of Medical Genetics, 102537. Advance online publication. https://doi.org/10.1016/j.gim.2026.102537

Michael is a genetic counselor at The City of Hope Orange County Lennar Foundation Cancer Center. 

• Master of Science, Genetic Counseling, 2021, University of Michigan, Ann Arbor, MI
• Bachelor of Arts, Integrative Biology, 2011, University of California Berkeley, Berkeley, CA 

Professional Experience 

• 2025-Present, Genetic Counselor, The City of Hope Orange County Lennar Foundation Cancer Center, Irvine, CA
• 2021-2025, Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
• 2020-2021, Project Consultant, Mainstream Genomics, San Mateo, CA
• 2018-2019, Genetic Counselor Assistant, University of California San Francisco (UCSF) Cancer Genetics and Prevention Program, San Francisco, CA
• 2016-2017, Clinical Research Coordinator, COTES Study UCSF Department of Psychiatry, San Francisco, CA
• 2012-2016, Staff Research Associate II, UCSF NRG Oncology Biospecimen Bank, San Francisco, CA 

Publications 

• Restrepo, M.L. (2021, September). Exploring Perspectives in a Diverse Patient Cohort on the Duty to Recontact with Updates to Variants of Uncertain Significance [Poster Presentation]. National Society of Genetic Counselors Annual Conference.
• Restrepo, M.L. (2021, April). The Responsibility to Recontact After Reporting VUS Results: Exploring Diverse Patient Perspectives on How to Stay Updated on Genetic Information [Thesis Presentation]. Department of Human Genetics Seminar, University of Michigan.

Elise is a genetic counselor in the Division of Clinical Cancer Genomics at City of Hope's Duarte and Antelope Valley, California, locations. She has a Master of Science in genetic counseling and a Master of Public Health in health management and policy from the University of Michigan. Before graduate school, she earned her Bachelor of Science in Biology and German Studies from Brandeis University.

Elise joined the Clinical Cancer Genomics team in July 2020 after graduating from the University of Michigan. Her graduate research focused on understanding barriers to genetic services for cancer in underserved populations and eliciting ideas for interventions to increase uptake. In addition to access to genetic services, her special interests include alternative service delivery models, genetic testing and privacy policies, and the intersection of public health and genetic counseling. 

Education 

• Master of Science, Genetic Counseling, 2020, University of Michigan, Ann Arbor, MI
• Master of Public Health (Health Management and Policy), 2020, University of Michigan, Ann Arbor, MI
• Bachelor of Science, Biology and German studies, magna cum laude, 2015, Brandeis University, Waltham, MA 

Professional Experience 

• 2023-present, Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
• 2020-2023, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
• 2018-2020, Student Administrative Assistant, Department of Pediatric Genetics, University of Michigan, Ann Arbor, MI
• 2016-2017, Patient Care Coordinator, Planned Parenthood of the Great Northwest and Hawaiian Islands, Bellevue, WA 

Eric is a genetic counselor in the Division of Clinical Cancer Genomics at City of Hope. 

Education 

• Master of Science, Human Genetics and Genetic Counseling, 2020, Stanford University, Stanford, CA
• Bachelor of Science in Biobehavioral Health, 2014, Pennsylvania State University, University Park, PA

Professional Experience 

• 2026-present, Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
• 2022-2025, Genetic Counselor/Care Navigator, Family Heart Foundation
• 2020-2022, Genetic Counselor I, Geisinger Genomic Medicine Institute, State College, PA

Publications

Pettit AR, Klaiman T, Kersting RC, Johnson C, Ogbuefi N, Moran M, Sinclair K, Steckel J, Norton L, Orr JA, Lieberman A, McGowan MP, Tricou E, Chen J, Rader DJ, Volpp KG, Beidas RS. A qualitative study of perceptions of the care pathway for familial hypercholesterolemia: screening, diagnosis, treatment, and family cascade screening. Implement Sci Commun. 2024 Dec 2;5(1):135. doi: 10.1186/s43058-024-00670-0. PMID: 39623509; PMCID: PMC11613662.

Campbell-Salome G, Morgan KM, Gabriel J, McGowan MP, Walters NL, Brangan A, Tricou EP, Rahm AK, Sturm AC, Jones LK. Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study. J Clin Lipidol. 2024 Sep-Oct;18(5):e832-e843. doi: 10.1016/j.jacl.2024.07.011. Epub 2024 Jul 31. PMID: 39278768; PMCID: PMC11606789.

Jones LK, Campbell-Salome G, Walters NL, Brangan A, Morgan KM, Tricou EP, Lindsey Mills ZT, McGowan MP, Gidding SS, Johns AM, Kirchner HL, Rahm AK, Sturm AC. IMPACT-FH Study for Implementing Innovative Family Communication and Cascade Testing Strategies for Familial Hypercholesterolemia. JACC Adv. 2024 Aug 14;3(9):101198. doi: 10.1016/j.jacadv.2024.101198. PMID: 39238848; PMCID: PMC11375316.

Morgan KM, Campbell-Salome G, Walters NL, Betts MN, Brangan A, Johns A, Kirchner HL, Lindsey-Mills Z, McGowan MP, Tricou EP, Rahm AK, Sturm AC, Jones LK. Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling. J Pers Med. 2024 Aug 9;14(8):841. doi: 10.3390/jpm14080841. PMID: 39202032; PMCID: PMC11355397.

Johnson C, Chen J, McGowan MP, Tricou E, Card M, Pettit AR, Klaiman T, Rader DJ, Volpp KG, Beidas RS. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial. Implement Sci. 2024 Apr 9;19(1):30. doi: 10.1186/s13012-024-01355-x. PMID: 38594685; PMCID: PMC11003060.

Hallquist MLG, Borensztein MJ, Coughlin CR 2nd, Buchanan AH, Andrew Faucett W, Peay HL, Smith ME, Tricou EP, Uhlmann WR, Wain KE, Ormond KE. Defining critical educational components of informed consent for genetic testing: views of US-based genetic counselors and medical geneticists. Eur J Hum Genet. 2023 Oct;31(10):1165-1174. doi: 10.1038/s41431-023-01401-0. Epub 2023 Jun 12. PMID: 37308598; PMCID: PMC10545703.

Tricou EP, Morgan KM, Betts M, Sturm AC. Genetic Testing for Familial Hypercholesterolemia in Clinical Practice. Curr Atheroscler Rep. 2023 May;25(5):197-208. doi: 10.1007/s11883-023-01094-2. Epub 2023 Apr 15. PMID: 37060538.

Walters NL, Lindsey-Mills ZT, Brangan A, Savage SK, Schmidlen TJ, Morgan KM, Tricou EP, Betts MM, Jones LK, Sturm AC, Campbell-Salome G. Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study. PEC Innov. 2023 Feb 4;2:100134. doi: 10.1016/j.pecinn.2023.100134. PMID: 37214500; PMCID: PMC10194298.

Campbell-Salome G, Jones LK, Walters NL, Morgan KM, Brangan A, Ladd IG, McGowan MP, Wilemon K, Schmidlen TJ, Simmons E, Schwartz MLB, McMinn MN, Tricou E, Rahm AK, Ahmed CD, Sturm AC. Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia. BMC Health Serv Res. 2023 Apr 5;23(1):340. doi: 10.1186/s12913-023-09304-y. PMID: 37020233; PMCID: PMC10074725.

Campbell-Salome G, Walters NL, Ladd IG, Sheldon A, Ahmed CD, Brangan A, McMinn MN, Rahm AK, Schwartz MLB, Tricou E, Fisher CL, Sturm AC. Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication. Transl Behav Med. 2022 Apr 16: doi: 10.1093/tbm/ibac018. Epub ahead of print. PMID: 35429393.

Ormond KE, Borensztein MJ, Hallquist MLG, Buchanan AH, Faucett WA, Peay HL, Smith ME, Tricou EP, Uhlmann WR, Wain KE, Coughlin CR 2nd, On Behalf Of The Clinical Genome CADRe Workgroup. Defining the Critical Components of Informed Consent for Genetic Testing. J Pers Med. 2021 Dec 5;11(12):1304. doi: 10.3390/jpm11121304. PMID: 34945775; PMCID: PMC8706495.

Hallquist MLG, Tricou EP, Ormond KE, Savatt JM, Coughlin CR 2nd, Faucett WA, Hercher L, Levy HP, O'Daniel JM, Peay HL, Stosic M, Smith M, Uhlmann WR, Wand H, Wain KE, Buchanan AH. Application of a framework to guide genetic testing communication across clinical indications. Genome Med. 2021 Apr 29;13(1):71. doi: 10.1186/s13073-021-00887-x. PMID: 33926532; PMCID: PMC8086064.

Hallquist MLG, Tricou EP, Hallquist MN, Savatt JM, Rocha H, Evans AE, Deckard N, Hu Y, Kirchner HL, Pervola J, Rahm AK, Rashkin M, Schmidlen TJ, Schwartz MLB, Williams JL, Williams MS, Buchanan A.H. Positive impact of genetic counseling assistants on genetic counseling efficiency, patient volume, and cost in a cancer genetics clinic. Genet Med. 2020 Aug;22(8):1348-1354. doi: 10.1038/s41436-020-0797-2. Epub 2020 Apr 30.

Schlomer GL, Cleveland HH, Feinberg ME, Greenberg M, Spoth R, Redmond C., Tricou EP, Vandenbergh DJ. Extending Previous cGxI Findings on 5-HTTLPR’s Moderation of Intervention Effects on Early Adolescent Substance Misuse Initiation. Child Dev. 2017 Nov;88(6):2001-2012. doi: 10.1111/cdev.12666. Epub 2016 Nov 8.

Kaila is a genetic counselor in the Division of Clinical Cancer Genomics at City of Hope in Duarte, California. 

Education 

• Master of Science, Human Genetics and Genetic Counseling, 2022, Keck Graduate Institute, Claremont, CA
• Bachelor of Arts, Psychology (with distinction), Gold LEAD Medallion Scholar, 2020, University of Windsor, Windsor, ON
• Bachelor of Science, Biology (Honors), Gold LEAD Medallion Scholar, 2019, University of Windsor, Windsor, ON 

Professional Experience 

• 2025-present, Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
• 2022-2025, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA

Publications 

• Senecal, J.B., Metcalfe, K., Wilson, K., Woldie, I., & Porter, L.A. (2021). Barriers to Translational Research in Windsor Ontario: a Survey of Clinical Care Providers and Health Researchers. Journal of Translational Medicine, 19(1). https://doi.org/10.1186/s12967-021-03097-6
• Eichhorn, S.H., El-Ballouli, A.O., Cassar, A., & Kaafarani, B.R. (2021). Columnar mesomorphism of board-shaped Perylene, Diketopyrrolopyrrole, Isoindigo, Indigo, and Quinoxalino-Phenanthrophenazine Dyes. Chempluschem, 86(2), 319–339. https://doi.org/10.1002/cplu.202100024 (Graphical Abstract)
• Pignanelli, J., Billet, B., Straeten, M., Prado, M., Schlingman, K., Ahamed, M.J., & Rondeau-Gagné, S. (2019). Imine and Metal–Ligand Dynamic Bonds in Soft Polymers for Autonomous Self-healing Capacitive-Based Pressure Sensors. Soft Matter, 15, 7654–7662. doi: 10.1039/c9sm01254k (Graphical Abstract)

Elyssa is a licensed, board-certified genetic counselor specializing in cancer genetics. She has a Master of Science in genetic counseling from the University of California, Irvine, and a bachelor’s degree from the University of California, Los Angeles, with a minor in Italian. Zukin joined City of Hope in 2020 as part of the Center for Precision Medicine. Her past research investigated clinical care implications for patients with genetic variants in genes associated with hereditary cancer syndromes that have conflicting interpretations by different genetics laboratories. She is also a member of the National Society of Genetic Counselors and the Southern California Genetic Counselors. 

Education 

• 2020, Master of Science in Genetic Counseling, University of California, Irvine 
• 2017, Bachelor of Science in Biology, Minor in Italian, University of California, Los Angeles 

Professional Experience 

•  2023-present, Genetic Counselor, Center for Precision Medicine, City of Hope, Duarte, CA 
• 2020-2023, Associate Genetic Counselor, Center for Precision Medicine, City of Hope, Duarte, CA 
• 2019-2020, Pediatric/NICU Genetic Counseling Assistant, Children’s Hospital of Orange County, University of California, Irvine 
• 2017-2018, Research Consent Specialist, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA 

Publications 

• Zukin, E., Culver, J. O., Liu, Y., Yang, Y., Ricker, C. N., Hodan, R., Sturgeon, D., Kingham, K., Chun, N. M., Rowe-Teeter, C., Singh, K., Zell, J. A., Ladabaum, U., McDonnell, K. J., Ford, J. M., Parmigiani, G., Braun, D., Kurian, A. W., Gruber, S. B., & Idos, G. E. (2023). Clinical implications of conflicting variant interpretations in the cancer genetics clinic. Genetics in medicine: official journal of the American College of Medical Genetics, 25(7), 100837. https://doi.org/10.1016/j.gim.2023.100837 
• Zhang, K., Liu, J., Truong, T., Zukin, E., Chen, W., & Saxon, A. (2017). Blocking allergic reaction through targeting surface-bound IgE with low-affinity anti-IgE antibodies. The Journal of Immunology, 198(10), 3823-3834.

Brittany leads a nurse-practitioner-run breast cancer survivorship program at City of Hope with over 1,000 patients under her care. She recently completed the City of Hope's Clinical Cancer Genetics program. She currently works in the high-risk screening and prevention clinic. 

Education 

• 2021-2022, Clinical Cancer Genetics Intensive Course, City of Hope, Duarte, CA 
• 2018, Chemotherapy Certification Course, City of Hope, Duarte, CA 
• 2010-2012, Master of Science, Nursing, Gerontology Acute-Care Nurse Practitioner, University of California, Los Angeles 
• 2001-2005, Bachelor of Science, Nursing, University of Manitoba, Winnipeg, Manitoba 

Professional Experience 

• 2021-present, High-Risk Screening and Prevention Nurse Practitioner, City of Hope, Duarte, CA 
• 2016-present, Breast Cancer Nurse Practitioner, City of Hope, Duarte, CA 
• 2012-2016, Medical Oncology and Hematology Nurse Practitioner, City of Hope, West Covina and Glendora, CA 

Publications 

• Bradford, B. (2012). Chemotherapy-induced infertility in patients with testicular cancer. Oncology Nursing Forum, 39(1):27-39. 
• City of Hope: Survivorship Handbook for Providers